Aprea Therapeutics
APRE
#9593
Rank
$19.01 M
Marketcap
$3.50
Share price
13.64%
Change (1 day)
-32.69%
Change (1 year)

Aprea Therapeutics (APRE) Fails to deliver data

Key failure to deliver metrics for Aprea Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Aprea Therapeutics (APRE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Aprea Therapeutics (APRE) - since 2023

Volume in USD (price x number of shares), data since 2023

Aprea Therapeutics (APRE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$0.37 M2.15%
2023$0.36 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
$0.07 M$0.99 M๐Ÿ‡บ๐Ÿ‡ธ USA
$8.14 M$13.43 M๐Ÿ‡บ๐Ÿ‡ธ USA